Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.28%
#4 aPriori aPriori +133.46%
#5 Bedrock Bedrock +71.29%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.40%
#8 Playnance Playnance +35.05%
#9 COTI COTI +29.45%
#10 Bitway Bitway +24.50%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Clasificación en acciones #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Precio por acción
$0.0009
Última sincronización: 2025-05-27
Capitalización bursátil
$1.15K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Arch Therapeutics, Inc. (ARTH)

Categoría

Healthcare
Ratio P/S de Arch Therapeutics, Inc. (ARTH)
Ratio P/S al August 2026 TTM: 0.01
Según los informes financieros más recientes y el precio de las acciones de Arch Therapeutics, Inc., el ratio P/S actual (TTM) es 0.01. Al final de 2022, el ratio P/S era 294.30.
Historial del ratio P/S de Arch Therapeutics, Inc. desde 2011 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.01 -99.99%
2023 52.78 -82.07%
2022 294.30 -88.10%
2021 2.47K 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 167,371.19%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 174,527.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 84,294.92%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR